Dr. Scott Tagawa Discusses IMMU-132 in Patients With Urothelial Carcinoma OncLive 1:31 8 years ago 386 Далее Скачать
Dr. Tagawa on Sacituzumab Govitecan in Urothelial Carcinoma OncLive 1:38 5 years ago 145 Далее Скачать
IMMU-132 - a novel antibody-drug conjugate for the treatment of lung cancer VJOncology 2:06 8 years ago 552 Далее Скачать
Dr. Tagawa Discusses the Development of Immunotherapy in Urothelial Cancer OncLive 2:04 7 years ago 166 Далее Скачать
Dr. Guarino on IMMU-132 in Advanced Metastatic Lung Cancer OncLive 1:09 9 years ago 523 Далее Скачать
Scott Tagawa, MD, on the Prostate Cancer Treatment Pipeline DocWire 4:13 4 years ago 138 Далее Скачать
Dr. Tagawa on Next Steps With Sacituzumab Govitecan in Advanced Urothelial Carcinoma OncLive 1:18 5 years ago 160 Далее Скачать
Dr. Tagawa on CTC in Neuroendocrine-Positive Prostate Cancer OncLive 2:06 10 years ago 351 Далее Скачать
Scott Tagawa, MD, on PSMA Targeting in Prostate Cancer Treatment DocWire 7:17 4 years ago 178 Далее Скачать
Use of Sacituzumab Govitecan in Metastatic Urothelial Carcinoma Targeted Oncology 1:10 5 years ago 128 Далее Скачать
Dr. Tagawa on BRCA2 in Patients with Prostate Cancer Receiving PSMA-Targeted Radionuclide Therapy OncLive 2:29 5 years ago 464 Далее Скачать
Dr. Tagawa Discusses Agents Targeted Against PSMA Targeted Oncology 1:31 9 years ago 256 Далее Скачать
Using Sacituzumab Govitecan and Other ADCs in Urothelial Cancers Targeted Oncology 1:11 5 years ago 185 Далее Скачать
Scott Tagawa, MD, on promising PSMA products in development for prostate cancer treatment OBRoncology 1:21 4 years ago 49 Далее Скачать
Scott Tagawa, MD, discusses the results of Phase I dose-escalation study regarding mCRPC OBRoncology 3:25 4 years ago 36 Далее Скачать
AMBASSADOR Study Findings and Adjuvant Treatment for Urothelial Carcinoma GU Oncology Now 8:12 10 months ago 105 Далее Скачать
